首页> 美国卫生研究院文献>Nephrology Dialysis Transplantation >Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker
【2h】

Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker

机译:尿Podocin:nephrin mRNA比(PNR)作为足细胞应激生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundProteinuria and/or albuminuria are widely used for noninvasive assessment of kidney diseases. However, proteinuria is a nonspecific marker of diverse forms of kidney injury, physiologic processes and filtration of small proteins of monoclonal and other pathologic processes. The opportunity to develop new glomerular disease biomarkers follows the realization that the degree of podocyte depletion determines the degree of glomerulosclerosis, and if persistent, determines the progression to end-stage kidney disease (ESKD). Podocyte cell lineage-specific mRNAs can be recovered in urine pellets of model systems and in humans. In model systems, progressive glomerular disease is associated with decreased nephrin mRNA steady-state levels compared with podocin mRNA. Thus, the urine podocin:nephrin mRNA ratio (PNR) could serve as a useful progression biomarker. The use of podocyte-specific transcript ratios also circumvents many problems inherent to urine assays.
机译:背景蛋白尿和/或蛋白尿广泛用于肾脏疾病的非侵入性评估。然而,蛋白尿是肾损伤,生理过程以及单克隆和其他病理过程中小蛋白过滤的多种形式的非特异性标志物。认识到足细胞耗竭的程度决定了肾小球硬化的程度,并且如果持续存在,则决定了发展为终末期肾病(ESKD)的机会是开发新的肾小球疾病生物标志物的机会。足细胞细胞谱系特异性的mRNA可以在模型系统的尿丸和人类中回收。在模型系统中,与podocin mRNA相比,进行性肾小球疾病与nephrin mRNA稳态水平降低有关。因此,尿podocin:nephrin mRNA比率(PNR)可以用作有用的进展生物标志物。足细胞特异性转录物比率的使用也规避了尿检定法固有的许多问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号